Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-08-28

FDA Approved: ERLOTINIB — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approves Teva's erlotinib original application, making a generic version available for the same uses as the reference product. The approved indications incl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ERLOTINIB (Erlotinib)

Snippet

ORIG AP for ERLOTINIB (ERLOTINIB)